The patients in our report improved symptomatically following treatment with calcium and an active vitamin D analogue (alphacalcidol), which normalized serum calcium and phosphorus levels, although they eventually developed hypercalcemia in association with progressive increase in serum PTH levels. The gene discussed is PTH; the disease is hypercalcemia disease.